Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Metlife (MET-PF) Cash & Current Investments (2016 - 2025)

Metlife has reported Cash & Current Investments over the past 17 years, most recently at $15.1 billion for Q4 2025.

  • Quarterly results put Cash & Current Investments at $15.1 billion for Q4 2025, down 11.46% from a year ago — trailing twelve months through Dec 2025 was $15.1 billion (down 11.46% YoY), and the annual figure for FY2025 was $15.1 billion, down 11.46%.
  • Cash & Current Investments for Q4 2025 was $15.1 billion at Metlife, down from $15.7 billion in the prior quarter.
  • Over the last five years, Cash & Current Investments for MET-PF hit a ceiling of $37.2 billion in Q2 2021 and a floor of $6.2 billion in Q4 2022.
  • Median Cash & Current Investments over the past 5 years was $15.7 billion (2024), compared with a mean of $17.7 billion.
  • Biggest five-year swings in Cash & Current Investments: surged 110.9% in 2021 and later tumbled 65.49% in 2022.
  • Metlife's Cash & Current Investments stood at $9.1 billion in 2021, then crashed by 31.87% to $6.2 billion in 2022, then surged by 45.64% to $9.1 billion in 2023, then soared by 88.13% to $17.1 billion in 2024, then fell by 11.46% to $15.1 billion in 2025.
  • The last three reported values for Cash & Current Investments were $15.1 billion (Q4 2025), $15.7 billion (Q3 2025), and $27.5 billion (Q2 2025) per Business Quant data.